CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Open-market sale Chief Legal Officer sold 15,000 shares at $18.90 ($283,496)
- 4 Open-market sale 10% owner sold 1,112,446 shares at an average $18.98 ($21,118,120)
- 4 Grant or award Chief Executive Officer acquired 26,667 shares (grant or award)
- 4 Open-market sale Director sold 1,900 shares at an average $20.21 ($38,406)
- 4 Open-market sale Director sold 1,707 shares at an average $20.21 ($34,498)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Other disposition 10% owner disposed of 2,614,157 shares (other)
- 4 Other disposition Director disposed of 2,614,157 shares (other)
- 4 Other disposition Director disposed of 2,614,157 shares (other)
- 4 Open-market sale Chief Executive Officer sold 18,470 shares at an average $20.76 ($383,393)
- 4 Open-market sale Chief Executive Officer sold 75,795 shares at an average $20.25 ($1,534,869)
- 4 Open-market sale Chief Business Officer sold 27,154 shares at an average $20.08 ($545,162)
- 4 Open-market sale Director sold 88,011 shares at $19.79 ($1,741,738)
- 4 Open-market sale Director sold 22,781 shares at an average $19.42 ($442,403)
- 4 Open-market sale Director sold 17,989 shares at $18.53 ($333,336)
- 4 Open-market sale Director sold 3,150 shares at an average $18.52 ($58,345)
- 4 Open-market sale Director sold 34,141 shares at an average $19.06 ($650,693)
- 4 Open-market sale Director sold 55,569 shares at an average $19.59 ($1,088,561)
- 4/A Insider Changes in Ownership
Page 21 of 26 · 502 filings